Proceeds benefit the MSK Cancer Health Equity Research and Care Initiative, dedicated to advancing equitable cancer care for ...

Two small studies published recently in Nature offer early, but important validation that stem cell treatments for Parkinson’s disease are viable. They also are a step toward a future where stem ...

New Jersey’s first standalone cancer hospital is opening later this month in New Brunswick, adding another specialty facility ...

Scientific Advisory Board (SAB) of clinical and scientific experts to advise it on its products designed to maximize the ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

Who wore what best? Step onto the annual Viennese Opera Ball, a dazzling gala that unites Austrian and American culture in ...

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

The treatments, one originally developed by a team at Memorial Sloan Kettering Cancer Center in New York and the other by researchers in Kyoto, Japan, are the culmination of decades of work to figure ...

CNN anchor and breast cancer patient Sara Sidner, Dr. Vinod Balachandran, and Novartis U.S. president Victor Bulto discussed progress and challenges in tackling the “evolving” disease at the 2025 ...

With a 95% retention rate for nurse residents completing the program and a 100% 2-year post-hire retention rate, these initiatives ensure a stable and well-trained workforce.

Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.

Yelena Y. Janjigian, MD, discusses how to manage the potential adverse events of pembrolizumab when using the recently ...